The James Buchanan Brady Urological Institute
 
 
 

Johns Hopkins Kidney Cancer Program



Johns Hopkins is on the forefront of kidney cancer research and our physicians are leaders in their field who offer the latest treatments and innovations.

SURGEONS:
JOHNS HOPKINS HOSPITAL:
Mohamad E. Allaf, MD
Trinity Bivalacqua, MD,PhD
Misop Han, MD
Phillip M. Pierorazio, M.D.

JOHNS HOPKINS BAYVIEW MEDICAL CENTER:
Christian Pavlovich, MD
Pravin Rao, MD
Stephen Schatz, MD

SIBLEY MEMORIAL HOSPITAL
Armine K. Smith, M.D.

MEDICAL ONCOLOGISTS:
Hans Hammers, MD
Jenny Kim, MD

PATHOLOGISTS:
George Netto, MD
Pedram Argani, MD

Diagnosed With Kidney Cancer



About 1/3 of kidney cancers are diagnosed after the disease has spread to other organs. The first step is to obtain a "staging" evaluation to determine the extent of cancer. This typically entails obtaining imaging of the chest, abdomen, and pelvis and comprehensive blood work. Bone scans and evaluations of the brain are obtained depending on symptoms and the results of the initial studies. PET scans are rarely obtained due to their lack of sensitivity for detecting kidney cancer.



Learn about Kidney Cancer?

Research



Clinical Trials

Johns Hopkins Studies

Research Endeavors






© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.| Disclaimer
Email: webmaster@urology.jhu.edu | 600 North Wolfe Street, Baltimore, Maryland 21287